PALMIERI, GIUSEPPE
 Distribuzione geografica
Continente #
AS - Asia 9.338
NA - Nord America 3.652
EU - Europa 2.089
SA - Sud America 1.530
AF - Africa 166
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 16.788
Nazione #
SG - Singapore 3.833
US - Stati Uniti d'America 3.451
CN - Cina 2.150
BR - Brasile 1.277
HK - Hong Kong 942
VN - Vietnam 850
IT - Italia 695
JP - Giappone 531
FR - Francia 505
KR - Corea 393
NL - Olanda 243
IN - India 150
GB - Regno Unito 120
DE - Germania 119
BD - Bangladesh 113
AR - Argentina 90
CA - Canada 90
FI - Finlandia 72
IL - Israele 67
MX - Messico 57
ID - Indonesia 51
ZA - Sudafrica 50
EC - Ecuador 44
AT - Austria 41
IE - Irlanda 38
IQ - Iraq 34
SA - Arabia Saudita 34
PL - Polonia 32
CO - Colombia 31
TR - Turchia 30
RU - Federazione Russa 27
UA - Ucraina 25
ES - Italia 24
MA - Marocco 24
VE - Venezuela 22
PK - Pakistan 21
TN - Tunisia 20
SE - Svezia 19
GR - Grecia 18
UY - Uruguay 18
EG - Egitto 17
KE - Kenya 17
MY - Malesia 17
PE - Perù 17
PY - Paraguay 17
PH - Filippine 16
UZ - Uzbekistan 16
AE - Emirati Arabi Uniti 15
JM - Giamaica 13
CZ - Repubblica Ceca 11
CH - Svizzera 9
CR - Costa Rica 9
DZ - Algeria 9
NO - Norvegia 9
NP - Nepal 9
PT - Portogallo 9
AL - Albania 8
AU - Australia 8
CL - Cile 8
KZ - Kazakistan 8
LT - Lituania 8
TH - Thailandia 8
BG - Bulgaria 7
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
BE - Belgio 5
BO - Bolivia 5
DO - Repubblica Dominicana 5
HN - Honduras 5
HU - Ungheria 5
LV - Lettonia 5
OM - Oman 5
RO - Romania 5
SK - Slovacchia (Repubblica Slovacca) 5
AM - Armenia 4
AO - Angola 4
CY - Cipro 4
DK - Danimarca 4
LK - Sri Lanka 4
MD - Moldavia 4
RS - Serbia 4
SI - Slovenia 4
BH - Bahrain 3
CU - Cuba 3
ET - Etiopia 3
GE - Georgia 3
GT - Guatemala 3
HR - Croazia 3
JO - Giordania 3
LB - Libano 3
LU - Lussemburgo 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
SN - Senegal 3
BB - Barbados 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
GA - Gabon 2
KH - Cambogia 2
MG - Madagascar 2
Totale 16.752
Città #
Singapore 2.241
Hefei 946
Hong Kong 936
Santa Clara 738
San Jose 552
Tokyo 468
Lauterbourg 410
Seoul 383
Ashburn 312
Ho Chi Minh City 301
Beijing 271
Hanoi 209
Dallas 171
New York 152
Los Angeles 148
Council Bluffs 143
São Paulo 131
Rome 65
Minamishinagawa 56
Buffalo 54
Helsinki 50
Milan 47
Frankfurt am Main 45
Cavallino 44
Naples 42
Rio de Janeiro 39
Cagliari 38
Orem 38
Guangzhou 37
Bengaluru 36
Dublin 36
Boardman 35
Da Nang 35
Amsterdam 31
Haiphong 31
Johannesburg 31
Belo Horizonte 30
Genoa 30
Vienna 29
Phoenix 26
Toronto 26
Montreal 25
London 23
Porto Alegre 23
San Gregorio di Catania 23
Chicago 22
Salvador 22
Curitiba 21
Nuremberg 21
Bari 19
Chennai 19
Dhaka 19
Hải Dương 19
Manchester 19
Warsaw 19
Mumbai 18
Paris 18
Sassari 18
Stockholm 18
Campinas 17
Riyadh 17
Brasília 16
Düsseldorf 15
Montevideo 15
Florence 14
Jakarta 14
Nairobi 14
Sala Baganza 14
Shanghai 14
Tashkent 14
Turin 14
Biên Hòa 13
Fortaleza 13
Guayaquil 13
Houston 13
Brooklyn 12
Charlotte 12
Goiânia 12
Hortolândia 12
Madrid 12
Mexico City 12
Buenos Aires 11
Denver 11
Jeddah 11
Quito 11
Quảng Ngãi 11
Turku 11
Betim 10
Boston 10
Kingston 10
Marseille 10
San Francisco 10
Thái Nguyên 10
Asunción 9
Atlanta 9
Baghdad 9
Can Tho 9
Casablanca 9
Catania 9
Changsha 9
Totale 10.300
Nome #
Four years of activity of the Melanoma Unit of Sassari across North Sardinia 116
Comparison between Three Different Techniques for the Detection of EGFR Mutations in Liquid Biopsies of Patients with Advanced Stage Lung Adenocarcinoma 92
Genome-wide association study of susceptibility loci for breast cancer in Sardinian population 86
ANTIPROLIFERATIVE ACTIVITY OF VANADIUM COMPOUNDS: EFFECTS ON THE MAJOR MALIGNANT MELANOMA MOLECULAR PATHWAYS 83
Anti- and Pro-Oxidant Activity of Polyphenols Extracts of Syrah and Chardonnay Grapevine Pomaces on Melanoma Cancer Cells 83
Triple-negative breast cancer frequency and type of BRCA mutation: Clues from Sardinia 80
Analisi di mutazioni somatiche e germinali in geni candidati 79
The role of NEMO (NF-kB essential modulator) binding domain (NDB) peptide in inducing apoptosis in A375 melanoma cell line. 78
Il CSCC: aspetti distintivi della patologia 76
Iodinated 4,4’‐bipyridines with antiproliferative activity against melanoma cell lines 76
Antitumoral effects of Vanadium compounds in malignant melanoma cell lines 76
Stable integration and expression in mouse cells of yeast artificial chromosomes harboring human genes. 74
Combination of mutations in genes controlling DNA repair and high mutational load plays a prognostic role in pancreatic ductal adenocarcinoma (PDAC): a retrospective real-life study in Sardinian population 74
Heterogeneous prevalence of mutations in KRAS, BRAF, and PIK3CA genes among Sardinian patients with colorectal carcinoma 73
Functionals interactions of the MAPK-ERK gene pathway in melanoma pathogenesis. 73
Antidiabetic potential of vanadium complexes combined with olive leaf extracts: a viable approach to reduce metal toxicity 73
Construction of a pilot YAC library in a recombinant-defective yeast strain 72
Germline and somatic NGS-based analysis on BRCA-related tumors 72
Attività anti-proliferativa e pro-apoptotica di bifenili derivati dall eugenolo e dall isoeugenolo su cellule tumorali di melanoma maligno. 71
What is changing in the adjuvant treatment of melanoma? 70
Multiple primary melanomas from same patients present discrepant somatic alterations in main candidate genes 70
A point mutation (G574A) in the chemokine receptor CXCR4 detected in human cancer cells enhances migration 70
A Functional Mammalian Target of Rapamycin Complex 1 Signaling Is Indispensable for c-Myc-Driven Hepatocarcinogenesis 69
Microsatellite instability and mutation analysis of candidate genes in unselected sardinian patients with endometrial carcinoma 69
Exploring interaction modes between polysaccharide-based selectors and biologically active 4,4'-bipyridines by experimental and computational analysis 68
Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe (R) Panel 68
Second primary melanoma on a patient undergoing vemurafenib therapy. A case report. 67
Anticancer activity of two novel hydroxylated biphenyl compounds toward malignant melanoma cells 67
Metronomic schedale of temozollomide with conventional dose of cisplatin in metastatic melanoma. 66
nalysis of Fanconi anemia genes in colorectal cancer. 65
Analisi mutazionali nei pazienti con tumori solidi 65
COLORECTAL CANCER EPIDEMIOLOGY IN AN AREA WITH A SPONTANEOUS SCREENING PROGRAM 65
COMPARATIVE ANALYSIS OF ENDOCANNABINOID SYSTEM GENE EXPRESSION ON METASTATIC VS PRIMITIVE MELANOMA CELL LINES. 65
Idiopathic pulmonary fibrosis (IPF) and lung cancer 65
Microsatellite instability in melanocytic skin lesions (benign nevi, dysplastic nevi, and primary melanomas along with their metastases) 64
Nanotecnologie Applicate alla classificazione MOlecolare delle MAlattie Complesse (NaMoMaC) 63
Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective 63
Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy 63
Current Trends in Mucosal Melanomas: An Overview 63
Genetic and molecular alterations in pancreatic cancer progression by next generation sequencing 63
Phenotype characterization of human melanoma cells resistant to Dabrafenib 62
Phytochemical evaluation and exploration of some biological activities of aqueous and ethanolic extracts of two species of the genus Plantago L 62
Molecular landscape profile of melanoma 62
Role of argininosuccinate synthetase (ASS) expression in response to arginine deiminase (ADI) in melanoma cell lines 61
PD-L1 Expression in Cutaneous Angiosarcomas: A Systematic Review with Meta-Analysis 61
KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors 61
Combination of vinorelbine, cisplatin, and etoposide in advanced non-small cell lung carcinoma: a pilot study. 60
A role of BRCA1 and BRCA2 germline mutations in breast cancer susceptibility within Sardinian population 60
Analoghi strutturali della curcumina come potenziali agenti antitumorali contro il melanoma maligno. 59
Genetic Instability Markers in Cancer 59
Comparison of BRAF Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients 59
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors 59
Liquid biopsy in clinical oncology 59
BRAF Mutations and Dysregulation of the MAP Kinase Pathway Associated to Sinonasal Mucosal Melanomas 59
Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study 58
Mutational status of main oncogenes and microsatellite instability in Sardinian patients with advanced colorectal cancer 58
The density and spatial tissue distribution of CD8(+) and CD163(+) immune cells predict response and outcome in melanoma patients receiving MAPK inhibitors 57
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013. 55
Screening genetico-molecolare del carcinoma della mammella e del cancro del colon-retto nel Nord Sardegna 55
In vitro and in vivo evaluation of the antitumour activity for a new curcumin-related compound in melanoma and neuroblastoma cells 55
KRAS mutations in non-small cell lung cancer: Translational aspects, current therapies and challenges for future research 54
Prevalence of BRCA1 and BRCA2 mutations in Sardinia. 54
Phenotype Characterization of Human Melanoma Cells Resistant to Dabrafenib. 54
Adjuvant therapy of cutaneous melanoma. 53
FUTURE PERSPECTIVES IN MELANOMA RESEARCH. Meeting report from the "Melanoma Research: A bridge from Naples to the World. Napoli, December 5 th-6 th2011" 53
Adjuvant treatment of malignant melanoma: Where are we? 52
Epidemiology and genetic susceptibility of malignant melanoma in North Sardinia, Italy 52
Molecular classification of patients with malignant melanoma for new therapeutic strategies. 52
AhR (Aryl Hydrocarbon Receptor) Polymorphisms: A Possible Role in TCDD (Dioxins)-AhR Binding and Carcinogenesis 52
Different pathogenetic mechanisms are underlying molecular alterations in fanconi and mismatch DNA repair genes among patients with colorectal carcinoma 51
Melanoma in children and adolescents: analysis of susceptibility genes in 123 Italian patients. 51
EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma 51
Preanalytic Variables and Tissue Stewardship for Reliable Next-Generation Sequencing (NGS) Clinical Analysis 50
BRAF testing techniques in the management of patients with advanced malignant melanoma: a real world comparative study 50
Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy? 50
Comparison of BRAF testing techniques in patients with advanced malignant melanoma: a real-life study. 50
Epithelioid cell-type melanoma as a prognostic factor of poor response to immunological treatment. 49
Le frontiere della diagnostica istopatologica e della genomica 49
Heterogeneous pathogenesis of melanoma: BRAF mutations and beyond 49
Studio epidemiologico sull'incidenza dei tumori nei lavoratori e nella popolazione della zona industriale di Porto Torres 48
Mutation analysis of candidate genes in melanoma-prone families: Evidence of different pathogenetic mechanisms at chromosome 9P21 48
Ngs-based analysis of atypical deep penetrating nevi 48
Antitumoral effect of vanadium compounds in malignant melanoma cell lines 48
Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study 48
Liquid biopsy-driven Cetuximab rechallenge strategy in molecularly selected metastatic colorectal cancer patients 48
High-grade epithelial carcinoma arising in a low-grade epithelial myoepithelial carcinoma of the parotid gland: A rare case report with immunohistochemical and molecular analysis 47
Genetic alterations at chromosome 9p21 and melanoma progression. 47
In vitro activity of the avb3 integrin antagonist RGDechi-hCit on malignant melanoma cells 46
Dioxin contamination in food chain: food and dioxins. 46
The enigmatic role of TP53 in germ cell tumours: Are we missing something? 46
Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th-1 December 1st, 2018, Naples, Italy) 45
AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in mela-noma treatment 45
Preparation of new hydroxylated natural-like biphenyls and their antitumoral activity. 44
Molecular Classification of Patients with Cutaneous Melanoma: A Reality 44
Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma 44
Perivascular epithelioid cell tumors (PEComas) of the orbit 43
Antiproliferative activity of eugenol and curcumin related biphenyls on malignant melanoma cell lines 43
Molecular Pathways in Melanomagenesis: What We Learned from Next-Generation Sequencing Approaches 43
Editorial: Advancements in Molecular Diagnosis and Treatment of Melanoma 43
Real Life Clinical Management and Survival in Advanced Cutaneous Melanoma: The Italian Clinical National Melanoma Registry Experience 42
Totale 6.008
Categoria #
all - tutte 56.541
article - articoli 42.680
book - libri 245
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.408
Totale 100.874


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202491 0 0 0 0 0 0 0 0 7 4 33 47
2024/20255.442 44 23 389 296 764 159 81 196 148 233 1.646 1.463
2025/202611.797 562 992 1.107 1.515 1.639 407 2.005 1.192 955 955 468 0
Totale 17.330